Drug Monitoring and Safety with Gilenya (fingolimod) for Multiple Sclerosis

Drug Monitoring and Safety with Gilenya (fingolimod) for Multiple Sclerosis

Publication date: Jan 30, 2018

Please remember, this video if for educational purposes only and doesn’t replace talking to your provider.

Fingolimod is a molecule that binds a receptor called the S1P Receptor. That receptor is expressed on MANY different kinds of human tissues. For this reason, fingolimod can have an effect on several different organ systems.

Here we discuss the suggested pre-testing prior to starting fingolimod (skin, exams labs, special eye test, EKG, cardiac and pulmonary history, evaluation of medications).

Then we review recommendations for monitors while taking fingolimod long term. (eye, labs, skin exams).

Thanks for watching. Please leave your questions or comments below!

OhioHealth MS Center Web page: http://ow.ly/GSUX30i2mtG

Follow us on Twitter: http://ow.ly/KuLB30i2muD

Like us on Facebook: http://ow.ly/gWqz30i2mvD

Follow us on Instagram: http://ow.ly/tZwt30i2mwS

Subscribe here on YouTube: http://ow.ly/PaVw30i2mzC



Please signin to view all article content and metadata.


Leave a Comment

Your email address will not be published. Required fields are marked *